NL194749B - Stabiel calciumhoudend farmaceutisch preparaat. - Google Patents

Stabiel calciumhoudend farmaceutisch preparaat.

Info

Publication number
NL194749B
NL194749B NL8701440A NL8701440A NL194749B NL 194749 B NL194749 B NL 194749B NL 8701440 A NL8701440 A NL 8701440A NL 8701440 A NL8701440 A NL 8701440A NL 194749 B NL194749 B NL 194749B
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparation
containing pharmaceutical
stable calcium
calcium
stable
Prior art date
Application number
NL8701440A
Other languages
English (en)
Other versions
NL8701440A (nl
NL194749C (nl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NL8701440A publication Critical patent/NL8701440A/nl
Publication of NL194749B publication Critical patent/NL194749B/nl
Application granted granted Critical
Publication of NL194749C publication Critical patent/NL194749C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
NL8701440A 1986-07-01 1987-06-19 Stabiel calciumhoudend farmaceutisch preparaat. NL194749C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8609515A FR2600893B1 (fr) 1986-07-01 1986-07-01 Nouvelles compositions pharmaceutiques a base de sels de calcium
FR8609515 1986-07-01

Publications (3)

Publication Number Publication Date
NL8701440A NL8701440A (nl) 1988-02-01
NL194749B true NL194749B (nl) 2002-10-01
NL194749C NL194749C (nl) 2003-02-04

Family

ID=9336917

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701440A NL194749C (nl) 1986-07-01 1987-06-19 Stabiel calciumhoudend farmaceutisch preparaat.

Country Status (31)

Country Link
US (1) US4867977A (nl)
JP (1) JPS6322522A (nl)
KR (1) KR950014449B1 (nl)
AT (1) AT392588B (nl)
AU (1) AU597992B2 (nl)
BE (1) BE1007686A4 (nl)
CA (1) CA1305057C (nl)
CH (1) CH674935A5 (nl)
CY (1) CY1684A (nl)
DE (1) DE3720510C2 (nl)
DK (1) DK173508B1 (nl)
ES (1) ES2006192A6 (nl)
FI (1) FI89329C (nl)
FR (1) FR2600893B1 (nl)
GB (1) GB2192131B (nl)
GR (1) GR871015B (nl)
HK (1) HK80393A (nl)
HU (1) HU199283B (nl)
IE (1) IE60430B1 (nl)
IL (1) IL83032A (nl)
IT (1) IT1216829B (nl)
LU (1) LU86932A1 (nl)
MY (1) MY101750A (nl)
NL (1) NL194749C (nl)
NO (1) NO175041B (nl)
NZ (1) NZ220898A (nl)
PH (1) PH25430A (nl)
PT (1) PT85212B (nl)
SE (1) SE502567C2 (nl)
SG (1) SG123192G (nl)
ZA (1) ZA874769B (nl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621486A5 (nl) * 1977-01-27 1981-02-13 Fischer Artur
JP2665764B2 (ja) * 1988-04-20 1997-10-22 日水製薬株式会社 カルシウム水溶液剤
EP0346866A3 (en) * 1988-06-16 1990-07-11 Biochemie Gesellschaft M.B.H. Composition for the prophylaxis of osteoporosis
EP0622992B1 (en) * 1991-12-26 1998-10-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
ES2089858T3 (es) * 1992-10-21 1996-10-01 Procter & Gamble Concentrados de premezcla para bebidas suplementados con calcio y estables en almacenamiento.
WO1994008471A1 (en) * 1992-10-21 1994-04-28 The Procter & Gamble Company Sweetener containing a concentrated bioavailable calcium source
WO1994008472A1 (en) * 1992-10-21 1994-04-28 The Procter & Gamble Company Concentrated bioavailable calcium source
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung
US5942255A (en) * 1996-07-15 1999-08-24 The University Of Memphis Methods of enhancing lean tissue mass and bone mineral content and compositions therefor
US6235322B1 (en) 1999-03-09 2001-05-22 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium
DE60231558D1 (de) * 2002-06-27 2009-04-23 Buendia Manuel Torres Verfahren zur herstellung von calciumgluconolactat, zusammensetzungen, verfahern und verwendungen davon
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
CA2520197A1 (en) * 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
US20040258818A1 (en) * 2003-06-20 2004-12-23 Kraft Foods Holdings, Inc. Reduced acidic flavor in acidified starch products
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US7323201B2 (en) * 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090298946A1 (en) * 2008-06-02 2009-12-03 Cleavelin Cody R Local Anesthetic Deactivation
WO2019126262A1 (en) * 2017-12-20 2019-06-27 Dsm Ip Assets B.V. Materials and methods for dietary calcium supplementation of animals
US20230000800A1 (en) * 2019-12-12 2023-01-05 Alberta Veterinary Laboratories Ltd. Choline bolus compositions for ruminants
CN113749205A (zh) * 2021-09-09 2021-12-07 山东凯翔生物科技股份有限公司 一种葡萄糖酸钙-葡萄糖酸复合粉的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1526981A (en) * 1923-02-02 1925-02-17 Upjohn Co Effervescent alkali compound and process of manufacturing and preparing the same
US1616587A (en) * 1926-08-25 1927-02-08 Upjohn Co Method of manufacturing effervescent alkali compounds
US1765867A (en) * 1928-12-15 1930-06-24 Henry G Granger Method for making candy
US2603569A (en) * 1950-01-23 1952-07-15 Joseph G Alther Effervescent drink concentrate
US2639238A (en) * 1952-07-02 1953-05-19 Joseph G Alther Effervescent drink concentrate
US3082091A (en) * 1956-07-03 1963-03-19 Pierre F Smith Effervescing composition in particle form
US3061445A (en) * 1959-04-30 1962-10-30 Abbott Lab Effervescent sweetening tablet
US3105792A (en) * 1960-11-29 1963-10-01 Warner Lambert Pharmaceutical Stable effervescent compositions and method of preparing same
US3241977A (en) * 1962-01-02 1966-03-22 Gen Foods Corp Effervescent beverage powders
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
US3489572A (en) * 1966-04-04 1970-01-13 Benjamin Eisenstadt Sweetening composition
DE2061370A1 (de) * 1969-12-15 1971-06-24 Sandoz Ag, Basel (Schweiz) Neue therapeutische Kombination
US3965273A (en) * 1973-04-02 1976-06-22 General Foods Corporation Dry carbonation source and method for preparing the same, and dry carbonated beverage concentrate
US3939289A (en) * 1973-04-02 1976-02-17 General Foods Corporation Dry carbonation source for a beverage concentrate and method of preparing the same
US4237147A (en) * 1974-01-04 1980-12-02 Monsanto Company Stabilized amorphous calcium carbonate
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US4009292A (en) * 1975-02-26 1977-02-22 General Foods Corporation Effervescent dipeptide sweetener tablets
US4206244A (en) * 1978-02-06 1980-06-03 Persian Delight, Inc. Dry mix for preparing a carbonated yogurt
JPS5585385A (en) * 1978-12-22 1980-06-27 Mitsuma Miyoshi Powdered food and drink
JPS57122925A (en) * 1981-01-26 1982-07-31 Ajinomoto Co Inc Tablet composition
US4551342A (en) * 1983-02-01 1985-11-05 The Procter & Gamble Company Beverages containing specific cation-edible acid mixtures for improved flavor impression
JPS59166057A (ja) * 1983-03-14 1984-09-19 Ajinomoto Co Inc ジペプチド甘味料含有発泡錠剤の製造法
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4760138A (en) * 1984-12-13 1988-07-26 Nestec S. A. Carbonating agents and their preparation
JPS62501843A (ja) * 1985-02-19 1987-07-23 ボ−ド・オブ・リ−ジェンツ・ザ・ユニバ−シティ−・オブ・テキサス・システム 食事のカルシウム補足によるオステオポロ−シス抑制
US4772467A (en) * 1985-02-19 1988-09-20 Board Of Regents, U T Systems Osteoporosis inhibition by dietary calcium supplementation
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby

Also Published As

Publication number Publication date
IL83032A0 (en) 1987-12-20
HK80393A (en) 1993-08-13
US4867977A (en) 1989-09-19
NL8701440A (nl) 1988-02-01
ATA164187A (de) 1990-10-15
IE871730L (en) 1988-01-01
IT8748100A0 (it) 1987-06-25
FR2600893B1 (fr) 1990-01-12
LU86932A1 (fr) 1988-01-20
FI872871A (fi) 1988-01-02
NO872712D0 (no) 1987-06-29
PT85212A (en) 1987-07-01
CH674935A5 (nl) 1990-08-15
PH25430A (en) 1991-07-01
HUT49481A (en) 1989-10-30
KR950014449B1 (ko) 1995-11-28
JPS6322522A (ja) 1988-01-30
IT1216829B (it) 1990-03-14
DK333487A (da) 1988-01-02
GB2192131A (en) 1988-01-06
PT85212B (pt) 1990-03-30
MY101750A (en) 1992-01-17
NO872712L (no) 1988-01-04
AU7491387A (en) 1988-01-07
AT392588B (de) 1991-04-25
FI89329C (fi) 1993-09-27
SE8702712L (sv) 1988-01-02
NO175041B (no) 1994-05-16
DE3720510A1 (de) 1988-01-07
DK333487D0 (da) 1987-06-29
AU597992B2 (en) 1990-06-14
NO175041C (nl) 1994-08-24
ZA874769B (en) 1989-02-22
SE502567C2 (sv) 1995-11-13
DE3720510C2 (de) 2002-12-19
CY1684A (en) 1993-10-10
CA1305057C (en) 1992-07-14
FI89329B (fi) 1993-06-15
SE8702712D0 (sv) 1987-06-30
BE1007686A4 (fr) 1995-10-03
NZ220898A (en) 1991-04-26
IL83032A (en) 1991-05-12
HU199283B (en) 1990-02-28
SG123192G (en) 1993-02-19
GB8715216D0 (en) 1987-08-05
GR871015B (en) 1987-11-02
GB2192131B (en) 1990-04-04
IE60430B1 (en) 1994-07-13
FI872871A0 (fi) 1987-06-29
DK173508B1 (da) 2001-01-15
ES2006192A6 (es) 1989-04-16
FR2600893A1 (fr) 1988-01-08
NL194749C (nl) 2003-02-04
KR880001295A (ko) 1988-04-22

Similar Documents

Publication Publication Date Title
NL194749B (nl) Stabiel calciumhoudend farmaceutisch preparaat.
DK195988D0 (da) Farmaceutisk praeparat indeholdende mikrokapsler
ES2015061B3 (es) Ingrediente antiespuma.
NO873534L (no) Stabilt farmasoeytisk gelpreparat.
DK184788A (da) Cytotoxisk praeparat
NO883591D0 (no) Dermal administreringsform.
DE3783437D1 (de) Heilmittel.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
NO873080D0 (no) Mikrobicid tilberedning.
DK413987D0 (da) Farmaceutiske praeparater
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
FI872733A (fi) Farmaceutiska kompositioner.
FI872313A0 (fi) Farmaceutiska kompositioner.
ATA327387A (de) Pharmazeutisches ranitidinpraeparat
NO874193D0 (no) Farmasoeytiske preparater.
FI874414A0 (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
DE3763519D1 (de) Heilnahrungsmittel.
MX172943B (es) Formulacion farmaceutica
DK447887D0 (da) Frysetoerrede farmaceutiske praeparater
FI875616A (fi) Farmaceutiska blandningar.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
MX9203545A (es) Formulaciones farmaceuticas.
DK428287D0 (da) Nasalt farmaceutisk praeparat
IT8719708A0 (it) Formulazione farmaceutica.
DK149588A (da) Xylometazolinholdige farmaceutiske praeparater

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20070619